Their findings are detailed in a study in mBio.
This is the third such gene discovered by researchers. When the first colistin resistance gene, mcr-1, emerged in an E. coli strain, it attracted “substantial attention worldwide,” according to the mBio study. Indeed, media heralded the bacteria as the “super” superbug.
A second colistin resistance gene, mcr-2, has also been discovered.
The new gene, mcr-3, was discovered when a colistin-resistant E. coli strain from a pig intestine tested negative for mcr-1 and mcr-2, the two previously known genes that conferred colistin resistance.
The results “suggest the likelihood of a wide dissemination of the novel mobile colistin resistance gene mcr-3” among other bacteria.
More articles on antibiotic resistance:
Survey: Some physicians open to financial penalties for inappropriate antibiotic prescription
FDA approves antibiotic for skin infections
CRE endemic across DC healthcare facilities, study suggests
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.